Home/Filings/4/0001062993-22-019485
4//SEC Filing

Campbell Michael Gerard 4

Accession 0001062993-22-019485

CIK 0001907685other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 5:25 PM ET

Size

4.9 KB

Accession

0001062993-22-019485

Insider Transaction Report

Form 4
Period: 2022-09-08
Campbell Michael Gerard
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-09-08$2.07/sh+25,000$51,75025,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.985 to $2.13, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Issuer

Comera Life Sciences Holdings, Inc.

CIK 0001907685

Entity typeother

Related Parties

1
  • filerCIK 0001934174

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 5:25 PM ET
Size
4.9 KB